Silence Therapeutics’ (SLN) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of Silence Therapeutics (NASDAQ:SLN – Free Report) in a research note ...
Forte Biosciences (FBRX) Expected to Announce Quarterly Earnings on Monday
Forte Biosciences (NASDAQ:FBRX – Get Free Report) is expected to release its earnings data before the market opens on Monday, March 17th. Analysts expect Forte Biosciences to post earnings of ($4.55) ...
Solid Biosciences (SLDB) Gets a Buy from Chardan Capital
Chardan Capital analyst Geulah Livshits maintained a Buy rating on Solid Biosciences (SLDB – Research Report) today and set a price target of ...
Iovance Biotherapeutics price target lowered to $30 from $34 at Chardan
Chardan lowered the firm’s price target on Iovance Biotherapeutics (IOVA) to $30 from $34 and keeps a Buy rating on the ...
Passage Bio price target lowered to $6 from $7 at Chardan
Chardan lowered the firm’s price target on Passage Bio (PASG) to $6 from $7 and keeps a Buy rating on the shares. The firm updated the ...
This Founder’s Gene Therapy Company Helped Blind Kids See Again
Zandy Forbes’ biotech company MeiraGTx has developed targeted gene therapy methods to treat more than just genetic disorders.
Why Urgent.ly (ULY) Stock Is Skyrocketing
Urgent.ly shares are trading higher by 66% during Thursday's session. The company announced it entered into a new credit ...
Dragonfly Energy Announces Corporate Debt Restructuring and Capital Raise
Detailed price information for Dragonfly Energy Hldgs Corp (DFLI-Q) from The Globe and Mail including charting and trades.
Ocugen (OCGN) Q4 2024 Earnings Call Transcript
Ocugen(NASDAQ: OCGN) Q4 2024 Earnings Call Mar 05, 2025, 8:30 a.m. ET ...
Urgent.ly Inc.: Urgently Announces Capital Structure Improvements and Secures up to $20 Million in New Financing
Urgent.ly Inc. (Nasdaq: ULY) ("Urgently"), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, announced ...